JAYTHARI Oral Suspension 22.75 mg/mL
Deflazacort · SUSPENSION · Zydus Pharmaceuticals (USA) Inc.
No Recall History
Plain English
JAYTHARI Oral Suspension is a suspension containing deflazacort at 22.75 mg/mL, taken oral. Manufactured by Zydus Pharmaceuticals (USA) Inc..
Key Facts
- Brand Name
- JAYTHARI Oral Suspension
- Generic Name
- Deflazacort
- NDC Code (Product)
70710-2131- Manufacturer
- Zydus Pharmaceuticals (USA) Inc.
- Strength
- 22.75 mg/mL
- Dosage Form
- SUSPENSION
- Route
- ORAL
- Marketing Status
- Application #
- ANDA220042
- Drug Class
- Corticosteroid [EPC]
- Marketing Start
- 11/20/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is JAYTHARI Oral Suspension used for?
JAYTHARI Oral Suspension contains Deflazacort. It is a suspension taken oral. Consult your doctor for specific uses.
Is JAYTHARI Oral Suspension a controlled substance?
JAYTHARI Oral Suspension is not classified as a controlled substance by the DEA.
What is the generic name for JAYTHARI Oral Suspension?
The generic name for JAYTHARI Oral Suspension is Deflazacort. There are 12 other brand versions of Deflazacort.
What is the NDC code for JAYTHARI Oral Suspension 22.75 mg/mL?
The NDC (National Drug Code) for JAYTHARI Oral Suspension 22.75 mg/mL is 70710-2131, listed by Zydus Pharmaceuticals (USA) Inc..